Related Experiment Video
Updated: Feb 18, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Haptoglobin genotypes in Chagas' disease
Susan E D C Jorge1, Cristina Feix Abreu, Maria Elena Guariento
1Department of Clinical Pathology, School of Medical Sciences, State University of Campinas-UNICAMP, São Paulo, Brazil.
Insights
Haptoglobin (Hp) genotype may influence Chagas
Area of Science:
- Genetics
- Cardiology
- Infectious Diseases
Background:
- Chagas' disease, caused by Trypanosoma cruzi, leads to significant cardiac complications.
- Haptoglobin (Hp) is a protein involved in inflammation and oxidative stress, potentially impacting disease progression.
Purpose of the Study:
- To explore the association between haptoglobin (Hp) genotypes and the severity of cardiac complications in Chagas' disease patients.
- Investigate the role of Hp polymorphism in the clinical evolution of Chagas' disease.
Main Methods:
- Haptoglobin (Hp) genotyping was conducted using Polymerase Chain Reaction (PCR).
- 107 Brazilian patients with Chagas' disease were analyzed, categorized into asymptomatic, mild heart disease, and severe heart disease groups.
Main Results:
- Multiple logistic regression analysis revealed an R-squared value of 24%.
- Patients with the Hp1-1 genotype demonstrated a reduced probability of developing severe cardiac complications.
Conclusions:
- Haptoglobin (Hp) polymorphism appears to be a significant factor influencing the clinical progression of Chagas' disease.
- The Hp1-1 genotype may confer a protective effect against severe heart complications in Chagas' disease.
Objectives:
To investigate the existence of an association between haptoglobin (Hp) genotypes and the severity of heart complications in Chagas' disease.
Design And Methods:
Hp genotyping was performed by PCR in 107 Brazilian patients sub-classified in asymptomatic, with mild heart disease and with severe heart disease.
Results:
Multiple logistic regression (R(2)=24%) indicated that patients with the Hp1-1 genotype have lower probability of developing the severe heart complications.
Conclusion:
The Hp polymorphism may influence the clinical evolution of Chagas' disease.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Principles of Pharmacogenetics: Types of Genetic Variants
Multiple Allele Traits
Genetic Lingo
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

